[Current management of arteriovenous malformations. Retrospective study of 31 cases and literature review]

F Muñoz1, P Clavel, J Molet

  • 1Servicios de Neurocirugía, Hospital Santa Creu i Sant Pau, Barcelona, Spain.

Neurocirugia (Asturias, Spain)
|November 17, 2007
PubMed

Insights

Treatment of high-grade Spetzler and Martin arteriovenous malformations (AVMs) requires careful consideration of patient factors and treatment modality. Preoperative embolization combined with surgery can yield good functional recovery, but requires specific embolization strategies to mitigate hemorrhage risks.

Area of Science:

  • Neurosurgery
  • Interventional Neuroradiology
  • Neurology

Background:

  • Arteriovenous malformations (AVMs) pose significant neurological risks, including hemorrhage and seizures.
  • High-grade AVMs (Spetzler and Martin grades III-V) present complex treatment challenges.
  • Optimal management strategies for these AVMs are continuously evolving.

Purpose of the Study:

  • To define therapeutic criteria for treating Spetzler and Martin grades III-V AVMs.
  • To analyze outcomes of preoperative embolization followed by surgery for these AVMs.

Main Methods:

  • Retrospective analysis of 31 patients with AVMs treated between 1999 and 2004.
  • Classification of AVMs using the Spetzler and Martin Grading Scale.
  • Evaluation of various treatment subgroups, including embolization plus surgery.

Main Results:

  • Nineteen patients had high-grade AVMs (III-V), treated with surgery, embolization plus surgery, or other methods.
  • Good functional recovery (modified Rankin 0-1) was achieved in 36.8% of patients.
  • A high rate of postembolization hemorrhage was noted in the embolization plus surgery group, though early surgery led to good recovery.

Conclusions:

  • Treatment decisions for cerebral AVMs should integrate natural history, clinical presentation, angiographic features, and patient condition.
  • For embolization plus surgery, recommend subtotal preoperative embolization (>50%) in staged sessions (4-6 weeks apart).
  • Advise surgery 1-3 weeks after the final embolization session to optimize outcomes and minimize risks.
Abstract